Bone marrow edema of the femoral head and transient osteoporosis of the hip.

Department of Radiology and Medical Imaging, Université Catholique de Louvain, University Hospital St Luc, Brussels, Belgium.
European Journal of Radiology (Impact Factor: 2.51). 08/2008; 67(1):68-77. DOI: 10.1016/j.ejrad.2008.01.061
Source: PubMed

ABSTRACT The current article of this issue aims at defining the generic term of bone marrow edema of the femoral head as seen at MR imaging. It must be kept in mind that this syndrome should be regarded, not as a specific diagnosis, but rather as a sign of an ongoing abnormal process that involves the femoral head and/or the hip joint. We aim at emphasizing the role of the radiologists in making a specific diagnosis, starting from a non-specific finding on T1-weighted images and by focusing on ancillary findings on T2-weighted SE or fat-saturated proton-density weighted MR images.

  • [Show abstract] [Hide abstract]
    ABSTRACT: There is no gold standard for treatment of bone marrow edema syndrome of the hip (BMESH). Usually, treatment is conservative, owing to the favorable and self-limiting prognosis. In musculoskeletal disorders, the effectiveness of extracorporeal shock wave therapy (ESWT) has been widely recognized and recent research supports its use in the treatment of the first stages of avascular osteonecrosis of the proximal femur and in other conditions where bone marrow edema is present. On this basis, we performed a prospective study to evaluate the effectiveness of ESWT in normalizing the symptoms and imaging features of BMESH. Twenty consecutive symptomatic patients underwent two treatments of high-energy ESWT and were followed-up at 2, 3 and 6 months, with a final clinical follow-up at mean 15.52 ± 1.91 months. Patients underwent magnetic resonance imaging of the hip and were evaluated according to the Harris hip score. The mean improvement in HHS over the course of the study was of 58.5 ± 14.9 points (p < 0.0001), and the mean edema area reduced from 981.9 ± 453.2 mm(2) pre-treatment to 107.8 ± 248.1 mm(2) at 6 months. ESWT seems to be a powerful, non-pharmacological tool that produces rapid pain relief and functional improvement and aids the normalization of the vascular and metabolic impairments which characterize BMESH.
    Rheumatology International 03/2014; · 2.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE. The objective of this study was to identify the risk factors associated with the prognosis and need for surgery of patients with subchondral insufficiency fractures of the femoral head. MATERIALS AND METHODS. Twenty-nine consecutively registered patients with subchondral insufficiency fractures of the femoral head were divided into the two groups: a non-progression of collapse group, which included patients who had no collapse or 2 mm or less of collapse of the femoral head and whose symptoms resolved (14 patients), and a progression of collapse group, which included patients who had more than 2 mm of collapse, for which surgery was indicated (15 patients). Both groups received the same conservative therapy. The following radiographic measurements were obtained: Sharp angle, center edge angle, acetabular roof angle, and acetabular head index. On MR images, band length, defined as the length of a low-signal-intensity band in the coronal plane, and band length ratio, defined as the proportion of the band length relative to the weight bearing portion, were assessed for each patient. Bone mineral density measurements (T score) were available for 17 patients. RESULTS. In the univariate analyses, T score, Sharp angle, center edge angle, acetabular roof angle, acetabular head index, band length, and band length ratio were found to be significant prognostic factors. Multivariate analyses of T score, acetabular head index, and band length ratio showed that both acetabular head index and band length ratio were signifi-cant predictors. CONCLUSION. Both acetabular head index and band length ratio are important prognostic factors in the care of patients with subchondral insufficiency fractures of the femoral head.
    American Journal of Roentgenology 07/2013; 201(1):W97-W103. · 2.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Transient osteoporosis is a relatively rare condition of unknown etiology that causes temporary bone loss. The syndrome is characterized by self-limited course and spontaneous resolution after 6 to 12 months. The pathogenesis of transient osteoporosis is not fully understood but several hypotheses that have been proposed include trauma, neurovascular dysfunction and transient hyperemia. Clinical manifestations include sudden onset of pain in the hip that usually worsens with weight bearing and leads to functional disability involving the affected extremity. Radiographs are frequently unremarkable, but may reveal periarticular osteopenia 3-6 weeks after the onset of clinical symptoms. There is no radiographic evidence of demineralization during the early phase of syndrome, as a result advanced imaging is required. Magnetic resonance imaging is the most sensitive and predictable test for an early diagnosis and monitoring of disease progression.
    Polish Journal of Radiology 01/2014; 79:36-38.

Full-text (2 Sources)

Available from
May 22, 2014